Inventor · disambiguated record
Csaba J. Peto
Also filed as: PETO CSABA · PETO CSABA J
27 granted patents·5 pending applications·225 citations·filing 1995–2024
96Inventor score
Top patents by PatentIndex Score
32 records- 0196US7803839B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2006·Granted Sep 28, 2010·46 cites·68 claims
- 0294US7915250B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2010·Granted Mar 29, 2011·22 cites·26 claims
- 0394US7704995B2Protein kinase modulators and methods of useEXELIXIS INC·Filed 2003·Granted Apr 27, 2010·64 cites·35 claims
- 0491US8372851B2Pyrazolo pyrimidines as casein kinase II (CK2) modulatorsEXELIXIS INC·Filed 2006·Granted Feb 12, 2013·20 cites·12 claims
- 0591US8362002B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2011·Granted Jan 29, 2013·12 cites·63 claims
- 0689US2025100966A1Mek inhibitors and methods of their useEXELIXIS INC·Filed 2024·Application pending·0 cites
- 0786US7576074B2Receptor-type kinase modulators and methods of useRICE KENNETH D·Filed 2003·Granted Aug 18, 2009·21 cites·47 claims
- 0883US11072600B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2017·Granted Jul 27, 2021·2 cites·42 claims
- 0983US10562886B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2016·Granted Feb 18, 2020·2 cites·39 claims
- 1082US11149025B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2020·Granted Oct 19, 2021·1 cites·18 claims
- 1180US8658654B2Receptor-type kinase modulators and methods of useRICE KENNETH D·Filed 2009·Granted Feb 25, 2014·3 cites·5 claims
- 1279US11560356B2Compounds and compositions for the treatment of cancerUNIV CALIFORNIA·Filed 2017·Granted Jan 24, 2023·2 cites·24 claims
- 1378US7846959B2Raf modulators and methods of useEXELIXIS INC·Filed 2005·Granted Dec 7, 2010·3 cites·21 claims
- 1474US11708352B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2021·Granted Jul 25, 2023·0 cites·19 claims
- 1574US11597699B2MEK inhibitors and methods of their useEXELIXIS INC·Filed 2020·Granted Mar 7, 2023·0 cites·1 claims
- 1673US8637499B2Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufactureAAY NAING·Filed 2010·Granted Jan 28, 2014·5 cites·23 claims
- 1773US8101625B2Pyrimidinones as Casein Kinase II (CK2) modulatorsRICE KENNETH D·Filed 2006·Granted Jan 24, 2012·2 cites·13 claims
- 1873US7872014B2Anaplastic lymphoma kinase modulators and methods of useEXELIXIS INC·Filed 2004·Granted Jan 18, 2011·7 cites·24 claims
- 1972US12145925B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2021·Granted Nov 19, 2024·0 cites·33 claims
- 2070US10640493B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2019·Granted May 5, 2020·0 cites·4 claims
- 2170US2020031770A1Mek inhibitors and methods of their useEXELIXIS INC·Filed 2019·Application pending·0 cites
- 2269US12227482B2Compounds and compositions for the treatment of cancerUNIV CALIFORNIA·Filed 2022·Granted Feb 18, 2025·0 cites·27 claims
- 2369US8012956B2Tropane compoundsEXELIXIS INC·Filed 2008·Granted Sep 6, 2011·1 cites·18 claims
- 2466US2019144382A1MEK Inhibitors and Methods of Their UseEXELIXIS INC·Filed 2018·Application pending·0 cites
- 2565US8648066B2Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufactureANAND NEEL KUMAR·Filed 2010·Granted Feb 11, 2014·2 cites·34 claims
- 2664US2014275527A1Azetidines as MEK Inhibitors for the Treatment of Proliferative DiseasesEXELIXIS INC·Filed 2013·Application pending·0 cites
- 2762US9359332B2Processes for the preparation of substituted quinazolinesSYMPHONY EVOLUTION INC·Filed 2013·Granted Jun 7, 2016·0 cites·12 claims
- 2860US10266518B2Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereofSYMPHONY EVOLUTION INC·Filed 2017·Granted Apr 23, 2019·0 cites·21 claims
- 2957US2017166523A9MEK Inhibitors And Methods Of Their UseEXELIXIS INC·Filed 2015·Application pending·0 cites
- 3054US9796704B2Substituted quinazolines as receptor-type kinase inhibitorsSYMPHONY EVOLUTION INC·Filed 2015·Granted Oct 24, 2017·0 cites·7 claims
- 3144US5849709ASaccharopeptides and derivatives thereofGLYCOMED INC·Filed 1995·Granted Dec 15, 1998·10 cites·3 claims
- 3242US8697737B2Raf modulators and methods of useANAND NEEL KUMAR·Filed 2010·Granted Apr 15, 2014·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Csaba J. Peto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →